000			a
999			_c9823 _d9823
003			OSt
005			20191023101321.0
008			191023b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_910058 _aTiwari, Gaurav
245			_aEthical and Administrative Implications of Nanoscale Technology for Efficient and Safe Delivery of Drugs _b:Analytical and Regulatory Aspects
250			_aVol.53(20, Apr-Jun
260			_aBengaluru _bIndian journal of pharmaceutical education and research _c2019
300			_a192-201p.
520			_aBackground: Cutting-edge issues for nanomedicine involve knowledge of the problems associated with toxicity and environmental effect of nanoscale substances (substances whose structure is on the dimensions of nanometers, i.e. billionths of a meter). Nanoparticles are able to reach inner biomolecules, which is not possible for larger debris. Materials and Methods: The nanosuspension turned into analytically characterized and subjected to regulatory aspects. Scientific facts used to make regulatory decisions about merchandise starting from cosmetics to chemotherapy agents to food packaging, FDA has lengthy encountered the combination of promise, threat and uncertainty that accompanies emerging technologies. Nanotechnology is not specific on this regard. Present article covered about regulatory aspects of Abbreviated New Drug Application (ANDA) and Registration, Evaluation, Authorisation and Restriction of Chemicals(REACH).Conclusion: The objective of this review is to know about the FDA regulations towards nanotechnology and various techniques used to analyze this tiny technology for drug delivery.
650		0	_94639 _aPHARMACEUTICS
700			_910059 _aTiwari, Ruchi
773	0		_tIndian journal of pharmaceutical education and research _dBengluru Association of Pharmaceutical Teachers of India (APTI) _x0019-5464
856			_uhttps://www.ijper.org/sites/default/files/IndJPhaEdRes_53_2_192.pdf _yClick here
942			_2ddc _cAR